Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North Texas

北德克萨斯州心血管和肺部疾病纳米技术跨学科培训

基本信息

  • 批准号:
    10206233
  • 负责人:
  • 金额:
    $ 24.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Although nanotechnology can be used to detect disease and improve the outcomes of cardiovascular and pulmonary healthcare, there are relatively few doctoral graduates that are trained to apply new advances in nanotechnology with a strong basic, health and translational science background. To bridge this gap, our long-term objective is to develop and operate a bioengineering doctoral training program in nanomaterials, nanoengineering and nanomedicine (DT-NEN) for cardiovascular and lung diseases. To reach this goal, we designed an integrative and interdisciplinary research training program for DT-NEN trainees by grouping participating mentors who have extensive training track records into four focused areas: (i) basic and translational sciences related to cardiovascular and lung diseases, (ii) nanoengineering strategies to facilitate vascular and lung tissue regeneration, (iii) nanomedicine for cardiovascular and lung diseases, and (iv) nanomaterials and imaging applications in detection of cardiovascular and lung disorders. Our DT-NEN program is novel as it will train doctoral students in various NEN applications for cardiovascular and lung diseases, including the use of NEN to study mechanisms involved with disease development and to facilitate tissue repair/regeneration and the traditional applications that are associated with the detection and treatment of these diseases. In addition to a new NEN curriculum, our DT-NEN trainees will also participate in several innovative training activities such as “I Engage Mentoring,” “Emerging Nanomedicine Landscape,” “Nanotechnology Risk and Toxicology Management” and “NEN Perception and Acceptance” to broaden their NEN experience. The program will also increase student involvement from underrepresented groups, especially the large Hispanic undergraduate population in Texas, via extensive recruitment activities, including “The Maverick Bridge Program,” “MavGrad Engineers” and “Students Recruiting Students.” The program will provide financial support to three pre-doctoral students in their second through third years, and the mentors and co-mentors will pay these trainees from their research grants thereafter. After completing the program, our trainees will be able to bridge the gap between theories and experiments, basic biology research and translational sciences as well as experimental and clinical applications associated with NEN for cardiovascular and lung diseases to bring these multidisciplinary fields together to facilitate improvements in the diagnosis and treatment of these diseases. Another outcome is that our DT-NEN program will provide outstanding training and research experiences to equip the next generation of investigators familiar with NEN advances in order to improve the detection and treatment efficiencies, thereby leading to better quality of life for many patients and lower associated healthcare costs. We also anticipate that the DT-NEN program will provide highly trained bioengineers, who will serve as the major workforce in various settings, including government agencies, hospitals, industrial and start-up companies as well as medical centers and universities.
虽然纳米技术可用于检测疾病和改善心血管疾病的结果, 肺保健,有相对较少的博士毕业生是受过训练,以应用新的进展, 纳米技术与强大的基础,健康和转化科学背景。为了弥补这一差距,我们 长期目标是开发和运行纳米材料生物工程博士培训计划, 纳米工程和纳米医学(DT-NEN)用于心血管和肺部疾病。为了实现这一目标,我们 设计了一个综合性和跨学科的研究培训计划,为DT-NEN学员分组 参与的导师在四个重点领域有广泛的培训记录:㈠基本和 与心血管和肺部疾病有关的转化科学,(ii)促进 血管和肺组织再生,(iii)用于心血管和肺疾病的纳米医学,和(iv) 纳米材料和成像应用在检测心血管和肺部疾病。我们的DT-NEN 该计划是新颖的,因为它将培养博士生在各种NEN应用心血管和肺 疾病,包括使用NEN研究与疾病发展有关的机制, 组织修复/再生以及与检测和治疗相关的传统应用 这些疾病。除了新的NEN课程,我们的DT-NEN学员还将参加几个 创新的培训活动,如“我从事指导”,“新兴纳米医学景观”, “纳米技术风险和毒理学管理”和“NEN的认知和接受”,以扩大其 NEN经验。该计划还将增加代表性不足的群体的学生参与, 特别是德克萨斯州大量的西班牙裔本科生,通过广泛的招聘活动,包括 “特立独行的桥梁计划”,“MavGrad工程师”和“学生招募学生”。该计划将 为三名博士预科学生提供第二年至第三年的经济支持,导师 其后,共同导师会从他们的研究赠款中支付给这些学员。完成课程后,我们 学员将能够弥合理论与实验,基础生物学研究和 转化科学以及与NEN相关的心血管实验和临床应用 和肺部疾病,将这些多学科领域结合在一起,以促进诊断和 这些疾病的治疗。另一个结果是,我们的DT-NEN计划将提供出色的培训 和研究经验,使下一代研究人员熟悉NEN的进展, 提高检测和治疗效率,从而提高许多患者的生活质量, 降低相关的医疗费用。我们还预计,DT-NEN计划将提供训练有素的 生物工程师,谁将作为主要劳动力在各种设置,包括政府机构, 医院、工业和初创公司以及医疗中心和大学。

项目成果

期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Investigating the Transient Regenerative Potential of Cardiac Muscle Using a Neonatal Pig Partial Apical Resection Model.
IR-783 Labeling of a Peptide Receptor for 'Turn-On' Fluorescence Based Sensing.
  • DOI:
    10.3390/chemosensors6040047
  • 发表时间:
    2018-10
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Eun-A Kwak;LeNaiya A. Kydd;Butaek Lim;J. Jaworski
  • 通讯作者:
    Eun-A Kwak;LeNaiya A. Kydd;Butaek Lim;J. Jaworski
Enhancing anti-thrombogenicity of biodegradable polyurethanes through drug molecule incorporation.
  • DOI:
    10.1039/c8tb01582a
  • 发表时间:
    2018-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Cancan Xu;A. Kuriakose;Danh Truong;Primana Punnakitikashem;K. Nguyen;Yi Hong
  • 通讯作者:
    Cancan Xu;A. Kuriakose;Danh Truong;Primana Punnakitikashem;K. Nguyen;Yi Hong
BetaBuddy: An end-to-end computer vision pipeline for the automated analysis of insulin secreting β-cells.
BetaBuddy:用于自动分析胰岛素分泌β细胞的端到端计算机视觉管道。
Luminescent Probe Based Techniques for Hypoxia Imaging.
  • DOI:
    10.15406/jnmr.2017.06.00160
  • 发表时间:
    2017-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    S. Sandhu;LeNaiya A. Kydd;J. Jaworski
  • 通讯作者:
    S. Sandhu;LeNaiya A. Kydd;J. Jaworski
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kytai Truong Nguyen其他文献

Shear Stress Reduces Protease Activated Receptor-1 Expression in Human Endothelial Cells
  • DOI:
    10.1114/1.1349700
  • 发表时间:
    2001-02-01
  • 期刊:
  • 影响因子:
    5.400
  • 作者:
    Kytai Truong Nguyen;Suzanne G. Eskin;Cam Patterson;Marschall S. Runge;Larry V. McIntire
  • 通讯作者:
    Larry V. McIntire
Lung Cancer Targeted Chemoradiotherapy via Dual-Stimuli Responsive Biodegradable Core-Shell Nanoparticles.
  • DOI:
    10.3390/pharmaceutics14081525
  • 发表时间:
    2022-07-22
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Iyer, Roshni;Ramachandramoorthy, Harish;Trinh Nguyen;Xu, Cancan;Fu, Huikang;Kotadia, Tanviben;Chen, Benjamin;Hong, Yi;Saha, Debabrata;Kytai Truong Nguyen
  • 通讯作者:
    Kytai Truong Nguyen

Kytai Truong Nguyen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kytai Truong Nguyen', 18)}}的其他基金

Synergistic Upregulation of EpoR /RopE NPs for Enhancing Effective Angiogenesis to treat PAD
EpoR /RopE NP 的协同上调可增强有效的血管生成以治疗 PAD
  • 批准号:
    10113347
  • 财政年份:
    2021
  • 资助金额:
    $ 24.85万
  • 项目类别:
Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North Texas
北德克萨斯州心血管和肺部疾病纳米技术跨学科培训
  • 批准号:
    9355415
  • 财政年份:
    2017
  • 资助金额:
    $ 24.85万
  • 项目类别:
Novel Engineered Particle Platform for Endothelium Regeneration
用于内皮再生的新型工程颗粒平台
  • 批准号:
    9198993
  • 财政年份:
    2014
  • 资助金额:
    $ 24.85万
  • 项目类别:
Novel Engineered Particle Platform for Endothelium Regeneration
用于内皮再生的新型工程颗粒平台
  • 批准号:
    8632706
  • 财政年份:
    2014
  • 资助金额:
    $ 24.85万
  • 项目类别:
Novel Engineered Particle Platform for Endothelium Regeneration
用于内皮再生的新型工程颗粒平台
  • 批准号:
    8788441
  • 财政年份:
    2014
  • 资助金额:
    $ 24.85万
  • 项目类别:
Nanoparticles for targeting drug delivery to the injured vascular wall
用于将药物递送至受损血管壁的纳米颗粒
  • 批准号:
    7837498
  • 财政年份:
    2009
  • 资助金额:
    $ 24.85万
  • 项目类别:
Nanoparticles for targeting drug delivery to the injured vascular wall
用于将药物递送至受损血管壁的纳米颗粒
  • 批准号:
    7569399
  • 财政年份:
    2008
  • 资助金额:
    $ 24.85万
  • 项目类别:
Nanoparticles for targeting drug delivery to the injured vascular wall
用于将药物递送至受损血管壁的纳米颗粒
  • 批准号:
    7354589
  • 财政年份:
    2008
  • 资助金额:
    $ 24.85万
  • 项目类别:
Enhanced endothelialization for tissue engineering
增强组织工程内皮化
  • 批准号:
    7011892
  • 财政年份:
    2006
  • 资助金额:
    $ 24.85万
  • 项目类别:
TISSUE ENGINEERED VASCULAR GRAFTS
组织工程血管移植物
  • 批准号:
    6491785
  • 财政年份:
    2001
  • 资助金额:
    $ 24.85万
  • 项目类别:

相似海外基金

Using base editing to investigate CFTR polymorphisms in lung diseases
使用碱基编辑研究肺部疾病中的 CFTR 多态性
  • 批准号:
    10833839
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
Bispecific immunotherapeutic delivery system for lung diseases
用于肺部疾病的双特异性免疫治疗递送系统
  • 批准号:
    10720773
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Lung Diseases
肺生物学和肺部疾病中的干细胞、细胞疗法和生物工程
  • 批准号:
    10753310
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
Novel gene therapy platform for monogenetic lung diseases
单基因肺部疾病的新型基因治疗平台
  • 批准号:
    491900
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Operating Grants
Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)
心肺疾病公平实施科学研究伙伴关系培训计划 (PRISE-HL T32)
  • 批准号:
    10553831
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
Exploring and Establishing Endotyping Markers in Obstructive Lung Diseases
探索和建立阻塞性肺疾病的内型标记物
  • 批准号:
    23K15204
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigation of airway mucin expression in the distal airway and alveolar regions of interstitial lung diseases
间质性肺疾病远端气道和肺泡区气道粘蛋白表达的研究
  • 批准号:
    22K21371
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Home-Returning Researcher Development Research)
Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases
特发性肺纤维化和其他进行性纤维化间质性肺疾病中的补体途径激活
  • 批准号:
    10590870
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
CMKLR1-Targeted Molecular Imaging of Inflammation as a Precision Medicine Tool in Acute Lung Injury and Fibrotic Lung Diseases
CMKLR1 靶向炎症分子成像作为急性肺损伤和纤维化肺疾病的精准医学工具
  • 批准号:
    10733483
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
Multidisciplinary Training Program in Pediatric Lung Diseases
小儿肺部疾病多学科培训计划
  • 批准号:
    10332256
  • 财政年份:
    2022
  • 资助金额:
    $ 24.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了